TRANSCENTA HOLDING LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.88 HKD | 0.00% |
|
+3.87% | -47.63% |
| 04-30 | Transcenta Holding Limited Announces Board and Nomination Changes | CI |
| 04-09 | Transcenta Partners with Agilent to Develop Claudin18.2 Companion Diagnostic | MT |
Chart calendar Transcenta Holding Limited
70ac150fd6b110a44e8.EmFZkP3Cg0nOmGSAAXQSGPFjmCe1RL9ltP42kccB5G8.UzER1cWN1j6p71a4dTdiTaMm_nTac_YhgLJBxfcskgVVWBDKn4vMHv7HPQ~eae78e31012dc7da056ffda873200725
Upcoming events on Transcenta Holding Limited
Past events on Transcenta Holding Limited
| 27/03/2024 | Q4 2023 Earnings Call |
| 26/03/2024 | Q4 2023 Earnings Release |
| 25/03/2024 02:00 | Extraordinary Shareholders Meeting |
| 19/10/2023 | European Society for Medical Oncology Congress - Abstract#: 1570P |
| 19/10/2023 | European Society for Medical Oncology Congress - Abstract#: 1556P |
| 19/10/2023 | European Society for Medical Oncology Congress - Abstract#: 4038 |
| 21/08/2023 | Q2 2023 Earnings Release |
| 09/06/2023 03:00 | Annual General Meeting |
| 07/06/2023 13:00 | Business Update Call |
| 05/06/2023 14:00 | American Society of Clinical Oncology Conference - Abstract#: TPS4176 |
| 05/06/2023 13:00 | American Society of Clinical Oncology Conference - Abstract#: 4046 |
| 17/04/2023 14:00 | American Association for Cancer Research Meeting - Abstract #1546 |
| 16/04/2023 18:30 | American Association for Cancer Research Meeting - Abstract #465 |
| 31/03/2023 03:00 | Q4 2022 Earnings Call |
| 29/03/2023 | Q4 2022 Earnings Release |
| 19/01/2023 20:00 | American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract Number: TPS476 |
| 14/11/2022 | Goldman Sachs Asia Pacific Healthcare Forum |
| 10/11/2022 14:00 | Society for Immunotherapy of Cancer Meeting - Abstract#: 105 |
| 10/11/2022 14:00 | Society for Immunotherapy of Cancer Meeting - Abstract#: 771 |
| 09/11/2022 14:30 | TEMTIA Meeting |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 50,2 50,0 0.48% | 102 72,7 40.17% | 53,8 121 -55.55% | 161 |
|
EBITDA Million CNY | Released Forecast Spread | -434 -463 6.11% | -399 -551 27.68% | -442 -561 21.26% | -279 |
|
EBIT Million CNY | Released Forecast Spread | -480 -526 8.62% | -442 -600 26.22% | -485 -628 22.77% | -324 |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 0,00 0,00 - | -407 -650 37.39% | -463 -621 25.43% | -309 |
|
Net income Million CNY | Released Forecast Spread | 0,00 0,00 - | -407 -650 37.42% | -463 -621 25.47% | -309 |
|
EPS CNY | Released Forecast Spread | 0,00 0,00 - | -0,94 -1,46 35.62% | -1,14 -1,45 21.38% | -0,76 |
| Announcement Date | 21/03/22 | 30/03/23 | 27/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 23,6 23,3 1.04% | 80,1 26,0 208.54% | 36,1 55,0 -34.42% | 17,8 86,2 -79.39% | 26,7 | 135 | |
|
EBIT Million CNY | Released Forecast Spread | -276 -321 14.12% | -216 -339 36.22% | -256 -214 -19.27% | -229 -244 6.19% | -197 | -127 | |
|
Net income Million CNY | Released Forecast Spread | -204 | ||||||
|
EPS CNY | Released Forecast Spread | -0,47 | -0,58 -0,46 -26.09% | -0,56 -0,51 -9.8% | -0,46 | -0,29 | ||
| Announcement Date | 21/03/22 | 29/08/22 | 30/03/23 | 22/08/23 | 27/03/24 | - | - |
More events
Past sector events for Transcenta Holding Limited
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 6628 Stock
- Calendar Transcenta Holding Limited
